Page last updated: 2024-12-05

creosol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Creosol is a naturally occurring organic compound that is a monomethyl ether of guaiacol. It is a colorless liquid with a pleasant, aromatic odor. Creosol is a component of creosote, a wood tar derivative that has been used for centuries as a preservative and antiseptic. Creosol has been shown to have a variety of biological activities, including antimicrobial, antioxidant, and anti-inflammatory effects. It is also a potential source of biofuel. Creosol is studied for its potential applications in medicine, agriculture, and energy production. It is of interest to researchers due to its unique chemical structure and its wide range of biological activities.'

Cross-References

ID SourceID
PubMed CID7144
CHEMBL ID3182715
CHEBI ID89886
SCHEMBL ID92236
MeSH IDM0084670

Synonyms (77)

Synonym
2-methoxy-4-methyl-phenol
creosol
p-creosol
4-methylguaiacol
4-methyl-2-methoxyphenol
93-51-6
homoguaiacol
4-hydroxy-3-methoxytoluene
nsc-4969
p-methylguaiacol
phenol, 2-methoxy-4-methyl-
nsc4969
p-cresol, 2-methoxy-
3-methoxy-4-hydroxytoluene
4-hydroxy-3-methoxy-1-methylbenzene
2-methoxy-4-methylphenol
2-methoxy-4-cresol
2-methoxy-p-cresol
kreosol [german]
fema no. 2671
cresolum drudum
nsc 4969
ai3-15891
1-hydroxy-2-methoxy-4-methylbenzene
brn 1862340
homocatechol monomethyl ether
einecs 202-252-9
4-methyl guaiacol
rohkcrsol
inchi=1/c8h10o2/c1-6-3-4-7(9)8(5-6)10-2/h3-5,9h,1-2h
2-methoxy-4-methylphenol, >=98%, fg
2-methoxy-4-methylphenol, natural, 97%, fg
2-methoxy-4-methylphenol, >=98%
M0114
AKOS000120520
kreosol
w9gw1kzg6n ,
unii-w9gw1kzg6n
dtxsid6047105 ,
NCGC00256731-01
cas-93-51-6
dtxcid4027105
tox21_302681
2-hydroxy-5-methylanisole
FT-0612795
creosol [mi]
2-methoxy-p- cresol
2-methoxy-4-methylphenol [fhfi]
valspice
SCHEMBL92236
2-methoxy-4-methyl phenol
phenol, 4-methyl-2-methoxy
Q-100894
CHEMBL3182715
chebi:89886 ,
mfcd00002378
F0001-2237
2-2-methoxy-4-methylphenol
2-methoxy-4-methylphenol, analytical standard
3-methoxy-4-methyl-phenol
2-methoxy-4-methylphenol (creosol)
fema 2671
2-methoxy-4-methylphenol (4-methylguaiacol)
p-methylguaicol
4-methyl-2-methoxyphenol (4-methylguaiacol)
homocatechol methyl ester
2-methoxy-4-methylphenol, 9ci
CS-W021711
BCP19090
Q403037
SY036778
AS-15967
EN300-18155
D70655
HY-W040971
2-methoxy-4-methylphenol--d3,od
Z57234300

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"Wood creosote, principally a mixture of non-, alkyl- and/or alkoxy-substituted phenolic compounds, was orally administered to adult male volunteers to determine its metabolites and pharmacokinetic parameters."( Pharmacokinetics of wood creosote: glucuronic acid and sulfate conjugation of phenolic compounds.
Matsushima, N; Ogata, N; Shibata, T, 1995
)
0.29

Bioavailability

ExcerptReferenceRelevance
" Isolation and identification of these metabolites may be used as references for in vivo bioavailability experiments and for investigating their bioactivity in in vitro experiments."( Development and Validation of an in vitro Experimental GastroIntestinal Dialysis Model with Colon Phase to Study the Availability and Colonic Metabolisation of Polyphenolic Compounds.
Bosscher, D; Breynaert, A; Claeys, M; Cos, P; Hermans, N; Kahnt, A; Pieters, L, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency39.15810.000221.22318,912.5098AID743035; AID743063
estrogen nuclear receptor alphaHomo sapiens (human)Potency48.97820.000229.305416,493.5996AID743075
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.63790.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency21.87510.143427.612159.8106AID1159516
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (21.57)18.7374
1990's4 (7.84)18.2507
2000's10 (19.61)29.6817
2010's23 (45.10)24.3611
2020's3 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.90 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index84.11 (26.88)
Search Engine Supply Index1.99 (0.95)

This Compound (53.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.77%)5.53%
Reviews1 (1.89%)6.00%
Case Studies1 (1.89%)4.05%
Observational0 (0.00%)0.25%
Other49 (92.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]